Page 141 - 南京医科大学自然版

第46卷第9期 孟明辉，陈正新，王慧博. 翻译后修饰介导的膜表面稳态调控与胶质母细胞瘤免疫可见性重塑［J］.
2026年9月 南京医科大学学报（自然科学版），2026，46（9）：1398-1411 ·1411 ·

cell⁃derived extracellular vesicles are critical for EV⁃cell ［88］VAN OPIJNEN M P，DE VOS F Y F，CUPPEN E，et al.
interaction and functional activation of endothelial cells［J］. The role of molecular biomarkers in recurrent glioblasto⁃
Int J Mol Sci，2022，23（17）：9539 ma trials：an assessment of the current trial landscape of
［79］HALLAL S，TUZESI Á，GRAU G E，et al. Understand⁃ genome⁃driven oncology［J］. Med Oncol，2024，41（11）：
ing the extracellular vesicle surface for clinical molecu⁃ 250
lar biology［J］. J Extracellular Vesicle，2022，11（10）： ［89］MENACEUR VANDENBROUCKE C，UNNIKRISHNAN

e12260 K，ITA M I，et al. Extracellular vesicles as liquid biopsy
［80］KUNADT M，ECKERMANN K，STUENDL A，et al. Extra⁃ tools for personalized therapeutic goals in glioblastoma［J］.
cellular vesicle sorting of α⁃synuclein is regulated by su⁃ Brain，2026，149（5）：1452-1468
moyl⁃ation［J］. Acta Neuropathol，2015，129（5）：695-713 ［90］LYUKMANOVA E N，KIRICHENKO A V，MEDYANIK I
［81］CHEN C H，ZHENG H H，LUO Y M，et al. SUMOylation A，et al. Extracellular vesicles from plasma of patients
promotes extracellular vesicle ⁃ mediated transmission with glioblastoma promote invasion of glioblastoma cells
of lncRNA ELNAT1 and lymph node metastasis in blad⁃ even after tumor resection［J］. Biomedicines，2024，12
der cancer［J］. J Clin Invest，2021，131（8）：e146431 （12）：2834
［82］LIU Y，ZHOU F，ALI H B，et al. Immunotherapy for glio⁃ ［91］ZHANG Z，LOBB R J，TOONEY P，et al. Monitoring glio⁃
blastoma：current state，challenges，and future perspec⁃ blastoma extracellular vesicle evolution using a nanodiag⁃
tives［J］. Cell Mol Immunol，2024，21（12）：1354-1375 nostic platform to detect glioma stem cells driving recur⁃
［83］MORENO ⁃ SANCHEZ P M，REZAEIPOUR M，INDER⁃ rent disease［J］. Sci Adv，2026，12（5）：eadt2804
BERG E M，et al. Immunosuppressive mechanisms and ［92］ZHANG X，LI J J，HUANG Y Y，et al. Plasma extracellu⁃
therapeutic interventions shaping glioblastoma immunity lar vesicles from recurrent GBMs carrying LDHA to acti⁃
［J］. Nat Cancer，2026，7（1）：29-42 vate glioblastoma stemness by enhancing glycolysis［J］.
［84］WEATHERS S P，LI X Q，ZHU H F，et al. Improved over⁃ Theranostics，2025，15（8）：3655-3672
all survival in an anti⁃PD⁃L1 treated cohort of newly diag⁃ ［93］KANSHA T，MA X J，WANG H，et al. Exosomal PD⁃L1
nosed glioblastoma patients is associated with distinct im⁃ detection in cancer predictive biomarker for response to
mune，mutation，and gut microbiome features：a single immune checkpoint blockade therapy［J］. Front Immunol，
arm prospective phase Ⅰ/Ⅱ trial［J］. Nat Commun， 2025，16：1603855
2025，16：3950 ［94］AIBAIDULA A，GHARIBI LORON A，BOUCHAL S M，
［85］YU K K H，BASU S，BAQUER G，et al. Investigative nee⁃ et al. Plasma extracellular vesicles as liquid biopsies for
dle core biopsies support multimodal deep ⁃ data genera⁃ glioblastoma：biomarkers，subpopulation enrichment，and
tion in glioblastoma［J］. Nat Commun，2025，16（1）：3957 clinical translation［J］. Int J Mol Sci，2025，26（23）：
［86］AJAIB S，WINTER⁃LUKE J，DIGBY R J，et al. Spatial 11686
profiling of longitudinal glioblastoma reveals consistent ［95］HALLAL S M，TuZESI Á，SIDA L A，et al. Glioblastoma
changes in cellular architecture，post⁃treatment［J］. Neu⁃ biomarkers in urinary extracellular vesicles reveal the po⁃
ro Oncol，2025，27（12）：3145-3160 tential for a‘liquid gold’biopsy［J］. Br J Cancer，2024，
［87］LANDRY A P，ELLENBOGEN Y，AJISEBUTU A，et al. 130（5）：836-851
Biomarkers of immunotherapy response in neuro⁃oncolo⁃ （收稿：2026-05-08；修回：2026-07-06；录用：2026-07-07）
gy［J］. Neuro Oncol Adv，2025，7（Suppl 4）：32-40 （本文编辑：唐 震）